Literature DB >> 12467072

p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China.

Tao Li1, Zhe-Ming Lu, Mei Guo, Qin-Jiao Wu, Ke-Neng Chen, Hai-Ping Xing, Qiang Mei, Yang Ke.   

Abstract

BACKGROUND: Human papillomavirus (HPV) plays an important role in the development of carcinomas at various body sites. It was found previously that the p53 codon 72 polymorphism (C/G) is a high-risk factor for the development HPV-associated cervical carcinoma. However, it still was considered controversial in several studies of cervical and esophageal carcinoma.
METHODS: In the current study, the authors used an allele specific polymerase chain reaction (PCR) method to analyze correlation between the p53 codon 72 (C/G) polymorphism and HPV-associated, noncancerous esophageal epithelium as well as esophageal, ovarian, and breast carcinoma in the Chinese population. Esophageal balloon cytology examination samples were obtained from high-incidence and low-incidence populations for esophageal carcinoma in Anyang (Henan Province).
RESULTS: Thirty-six of 48 esophageal balloon samples from the high-incidence population were HPV positive, and 13 of 33 esophageal balloon samples from the low-incidence population were HPV positive. Thirty-nine of 62 esophageal carcinoma samples from Anyang Tumor Hospital were HPV positive. Twenty-six of 39 ovarian carcinoma samples from the Second Affiliated Hospital of Inner Mongolia Medical College were HPV positive. Nineteen of 82 breast carcinoma samples from Beijing Cancer Hospital were HPV positive. It is noteworthy that the distribution of the p53 codon 72 Arg homozygous genotype in HPV positive samples of esophageal epithelium, ovarian carcinoma, and breast carcinoma was significantly higher compared with HPV negative tumor samples. (P < 0.05).
CONCLUSIONS: The current results suggest that the p53 codon 72 Arg homozygous genotype is one of the high-risk genetic factors for HPV-associated malignancies among the Chinese population. Copyright 2002 American Cancer Society.DOI 10.1002/cncr.11008

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467072     DOI: 10.1002/cncr.11008

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  29 in total

1.  Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk.

Authors:  Su-Qin Shen; De-Ke Jiang; Guo-Yuan Liu; Fang Chen; Long Yu
Journal:  Mol Biol Rep       Date:  2011-09-28       Impact factor: 2.316

2.  Individual and combined effects of MDM2 SNP309 and TP53 Arg72Pro on breast cancer risk: an updated meta-analysis.

Authors:  Hongtao Cheng; Biao Ma; Ran Jiang; Wei Wang; Hui Guo; Na Shen; Dapeng Li; Qunzi Zhao; Rui Wang; Pengfei Yi; Yue Zhao; Zeming Liu; Tao Huang
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

Review 3.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

4.  TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis.

Authors:  De-Ke Jiang; Lei Yao; Wen-Zhang Wang; Bo Peng; Wei-Hua Ren; Xian-Mei Yang; Long Yu
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

5.  p53 polymorphism in human papillomavirus-associated Kazakh's esophageal cancer in Xinjiang, China.

Authors:  Xiao-Mei Lu; Yue-Ming Zhang; Ren-Yong Lin; Xiao-Hui Liang; Ya-Lou Zhang; Xing Wang; Yan Zhang; Yan Wang; Hao Wen
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

6.  Human papillomavirus infection and sporadic breast carcinoma risk: a meta-analysis.

Authors:  Ni Li; Xiaofeng Bi; Yawei Zhang; Ping Zhao; Tongzhang Zheng; Min Dai
Journal:  Breast Cancer Res Treat       Date:  2010-08-26       Impact factor: 4.872

7.  p53 codon 72 polymorphism in basal cell carcinoma of the skin.

Authors:  Abdulmohammad Pezeshki; Fatemeh Sari-Aslani; Abbas Ghaderi; Mehrnoosh Doroudchi
Journal:  Pathol Oncol Res       Date:  2006-03-23       Impact factor: 3.201

Review 8.  The possible involvement of virus in breast cancer.

Authors:  Marla Karine Amarante; Maria Angelica Ehara Watanabe
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-14       Impact factor: 4.553

9.  p53 codon 72 polymorphism and breast cancer risk: A meta-analysis.

Authors:  Jing Hou; Yuan Jiang; Wenru Tang; Shuting Jia
Journal:  Exp Ther Med       Date:  2013-03-20       Impact factor: 2.447

Review 10.  Alterations of the TP53 gene in gastric and esophageal carcinogenesis.

Authors:  Marilanda Ferreira Bellini; Aline Cristina Targa Cadamuro; Maysa Succi; Marcela Alcântara Proença; Ana Elizabete Silva
Journal:  J Biomed Biotechnol       Date:  2012-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.